Skip to content
akaturk Academic measurement
2025 SJR Q3 JCR Q4 · 0,7 OA 15 matched articles ESCI

Journal detail

Case Reports in Dermatology

Publisher
S. Karger AG
Country
Switzerland · Western Europe
Type
journal
ISSN
  • 16626567
Scopus 0,308 SJR
Scopus Q3 SJR Q
WoS Q4 JCR Q
WoS 0,7 JIF
Scopus 26 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,308
  • Quartile Q3
  • H-Index 26
  • Cites/doc 0,74
  • Docs (3y) 143
  • Cites (3y) 136

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,7
  • 5Y JIF 0,9
  • JCI 0,32

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Dermatology Q3

Areas

  • Medicine

WoS categories

  • Dermatology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 Q4 0,308 0,7 0,9 0,32 Q4 26
2024 Q3 Q4 0,413 0,8 0,9 0,36 Q4 25
2023 Q3 Q4 0,292 0,9 1 0,33 Q4 25
2022 Q3 0,288 0,9 0,9 0,31 Q4 25
2021 Q3 0,295 0,33 Q4 25
2020 Q3 0,338 0,35 Q4 25
2019 Q3 0,324 25
2017 Q3 0,4 25
2016 Q3 0,291 25
2015 Q3 0,388 25
2014 Q3 0,275 25
2013 Q3 0,365 25
2012 Q3 0,241 25
2011 Q4 0,124 25
2010 25

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 DERMATOLOGY ESCI Q4 Q4 86/99
2024 DERMATOLOGY ESCI Q4 Q4 80/96
2023 DERMATOLOGY ESCI Q4 Q4 78/94
2022 DERMATOLOGY ESCI Q4
2021 DERMATOLOGY ESCI Q4
2020 DERMATOLOGY ESCI Q4